These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4963783)

  • 1. Mechanism for the pyridoxal neutralization of isoniazid action of Mycobacterium tuberculosis.
    Beggs WH; Jenne JW
    J Bacteriol; 1967 Oct; 94(4):793-7. PubMed ID: 4963783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid uptake in relation to growth inhibition of Mycobacterium tuberculosis.
    Beggs WH; Jenne JW; Hall WH
    J Bacteriol; 1968 Aug; 96(2):293-7. PubMed ID: 4970644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-pyridoxal phosphate interactions.
    Ebadi M; Gessert CF; Al-Sayegh A
    Q Rev Drug Metab Drug Interact; 1982; 4(4):289-331. PubMed ID: 6087425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pyridoxal on uptake of C14-activity from labeled isoniazid by Mycobacterium tuberculosis.
    BOONE IU; STRANG VG; ROGERS BS
    Am Rev Tuberc; 1957 Oct; 76(4):568-78. PubMed ID: 13470306
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.
    Takayama K; Wang L; David HL
    Antimicrob Agents Chemother; 1972 Jul; 2(1):29-35. PubMed ID: 4208567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the action of isoniazid.
    Youatt J
    Am Rev Respir Dis; 1969 May; 99(5):729-49. PubMed ID: 4306211
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial cells and the medium following the growth of tubercle bacilli in the liquid medium. III. The changes following the growth of BCG and the bovine type tubercle bacilli strain No. 10 in sauton's medium.
    ASAMI N; HOSOI M; TSUCHIYA K; UENO K; TSUCHIDA S; MIURA K
    Kekkaku; 1953 Apr; 28(4):202-3. PubMed ID: 13085531
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary drug resistance: a continuing survey of tubercle bacilli in a veteran population within the United States. 8. The influence of culture medium on the observed frequency of resistance.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1971 May; 103(5):722-4. PubMed ID: 4996270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of pH of the medium and other factors on the selection of isoniazid-resistant forms of M. tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1975; (9):68-71. PubMed ID: 6956
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity of isoniazid on growth inhibition and competition for an oxidized nicotinamide adenine dinucleotide regulatory site on the electron transport pathway in Mycobacterium phlei.
    Davis WB; Weber MM
    Antimicrob Agents Chemother; 1977 Aug; 12(2):213-8. PubMed ID: 197885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposures.
    Beggs WH; Jenne JW
    Tubercle; 1969 Dec; 50(4):377-85. PubMed ID: 4983736
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis.
    Wang L; Takayama K
    Antimicrob Agents Chemother; 1972 Dec; 2(6):438-41. PubMed ID: 4207759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.
    Quémard A; Lacave C; Lanéelle G
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1035-9. PubMed ID: 1656850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on the effect of the combined use of 1314 Th and INH to INH-resistant tubercle bacilli from the view-point of 14C-INH uptake].
    Takae S
    Kekkaku; 1967 Apr; 42(4):119-28. PubMed ID: 4965143
    [No Abstract]   [Full Text] [Related]  

  • 15. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.
    David HL
    Appl Microbiol; 1970 Nov; 20(5):810-4. PubMed ID: 4991927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
    Goldstein E; Eagle MC; LaCasse ML
    Appl Microbiol; 1971 Sep; 22(3):329-33. PubMed ID: 4330314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accelerated determination of the Mycobacterium tuberculosis drug resistance with a semiliquid culture medium].
    Manicheva OA; Vishnevskiĭ BI; Miakotina EN
    Klin Lab Diagn; 2003 Jul; (7):50-2. PubMed ID: 12934337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.
    MCCUNE RM; TOMPSETT R
    J Exp Med; 1956 Nov; 104(5):737-62. PubMed ID: 13367341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the biochemical changes in the bacterial cells and the medium following the growth of tubercle bacilli in the liquid medium. II. The changes following the growth of human type tubercle bacilli H2 strain and H37 strain in Sauton's medium].
    ASAMI N; HOSOI M; TSUCHIYA K; UENO K; TSUCHIDA S; MIURA K
    Kekkaku; 1953 Mar; 28(3):117-21. PubMed ID: 13085523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.